SHOCK杂志投稿须知
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
INSTRUCTIONS FOR AUTHORS
SHOCK\V Injury,Inflammation,and Sepsis:Labora-tory and Clinical Approaches
Online Submission and Review System
Scope
The mission of SHOCK\is to foster and promote multidisciplinary studies,both experimental and clinical in nature,that critically examine the etiology,mechanisms,and novel therapeutics of shock-related patho-physiological conditions.The journal will consider papers in the areas of basic and clinical studies of shock,trauma,sepsis,inflammation,isch-emia,and related pathobiological states,with particular emphasis on the biologic mechanisms that determine the response to such injury. Ethical/Legal Considerations
A submitted manuscript must be an original contribution not previously published(except as an abstract or a preliminary report),must not be under consideration for publication elsewhere,and,if accepted,must not be published elsewhere in similar form,in any language,without the consent of Lippincott Williams&Wilkins.Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts,the final responsibility rests with the authors,not with the Journal,its editors,or the publisher.
Patient Anonymity and Informed Consent V It is the author’s respon-sibility to ensure that a patient’s anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s)with which all the authors are affiliated. Authors should mask patients’eyes and remove patients’names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.
Conflicts of Interest V Authors must state all possible conflicts of interest in the manuscript,including financial,consultant,institutional, and other relationships that might lead to bias or a conflict of interest.If there is no conflict of interest,this should also be explicitly stated as none declared.All sources of funding should be acknowledged in the manuscript.All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading‘‘Conflicts of Interest and Source of Funding.’’
For example:
Conflicts of Interest and Source of Funding:‘‘Author A’’has received honoraria from‘‘Company1.’’‘‘Author B’’is currently receiving a grant (no.12345)from‘‘Organization Y’’and is on the speaker’s bureau for ‘‘Organization X’’V the CME organizers for Company1.For the remaining authors,none were declared.
Copyright V In addition,each author must complete and submit the journal’s Copyright Transfer Agreement,which includes a section on the disclosure of potential conflicts of interest based on the recommendations of the International Committee of Medical Journal Editors,‘‘Uniform Require-ments for Manuscripts Submitted to Biomedical Journals’’(/ update.html).The form is available on the manuscript submission page,https:// /shock/,and can be completed and submitted electronically.Please note that authors may sign the Copyright Transfer Agreement form electronically.For additional information about electroni-cally signing this form,go to /ZUA T/A106.
Compliance With NIH and Other Research Funding Agency Accessibility Requirements V A number of research funding agencies now require or request authors to submit the postprint(the article after peer review and acceptance but not the final published article)to a repository that is acces-sible online by all without charge.As a service to our authors,LWW will identify to the National Library of Medicine(NLM)articles that require deposit and will transmit the postprint of an article based on research funded in whole or in part by the National Institutes of Health,Wellcome Trust, Howard Hughes Medical Institute,or other funding agencies to PubMed Central.The revised Copyright Transfer Agreement provides the mechanism.
Permissions V Authors must submit written permission from the copy-right owner(usually the publisher)to use direct quotations,tables,or illustrations that have appeared in copyrighted form elsewhere,along with complete details about the source.Any permission fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material,not the responsibility of Lippincott Williams&Wilkins.Publication Policy
SHOCK\publishes regular Research Articles,Rapid Communications, Review Articles,and Letters to the Editor.Please note that SHOCK\does not publish Case Reports.Rapid Communications should be brief reports of especially important and timely findings in the field.Published length should be three to four pages,including figures and references.Reviews will be by invitation of the editor,but recommendations for topics and authors are welcomed.The editor also invites letters expressing comments on dissenting opinions concerning papers recently published in SHOCK\. Letters must not exceed500words and should be submitted double-spaced with any references prepared as for regular research reports.Publication of submitted letters will be at the discretion of the editor.Each author should include his/her complete address,along with telephone,fax,and e-mail.All submitted manuscripts will be critically refereed by at least two members of the editorial board or expert consultants.
Preparation of Manuscript
Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
Online Manuscript Submission V Authors are requested to submit their manuscripts online at /shock.
First-Time Users V Please click the Register button from the main menu and enter the requested information.On successful registration, you will be sent an e-mail indicating your user name and password. Print a copy of this information for future reference.Note:If you have received an e-mail from us with an assigned user ID and password,or if you are a repeat user,do not register again,just log in.Once you have an assigned ID and password,reregistration is unnecessary,even if your status changes(i.e.,author,reviewer,or editor).
Authors V Please click the log-in button from the menu at the top of the page and log in to the system as an Author.Submit your manuscript according to the author instructions to the editor:Dr.Irshad H.Chaudry, University of Alabama at Birmingham,Shock Editorial Office,1670 University Boulevard,V olker Hall,Room G094,Birmingham,AL35294-0119).You will be able to track the progress of your manuscript through the system.If you experience any problems,please contact the SHOCK\ Cover Letter V A cover letter should accompany all manuscripts submitted to SHOCK\,indicating that the manuscript has been submitted solely to this journal and has not previously been published in any form in another publication of any type,with the exception of preliminary reports in abstract form.In situations where the review of the submitted manu-script depends highly upon another manuscript submitted for publication but not yet published,a copy of that manuscript should be included with the submission.
Manuscripts must be typewritten and double-spaced.Number all pages in sequence beginning with the title page.The sections should be arranged in the following order:
Title Page V Include on the title page(a)complete manuscript title;
(b)authors’full names and affiliations;(c)corresponding author’s name and address,degree(s),fax number,telephone number,and e-mail address;
(d)address for reprints if different from that of corresponding author;
(e)all sources of support,including pharmaceutical and industry support,or a statement of no relevant conflicts of interest;and(f)a running head of not more than45characters.
The title page must also include disclosure of funding received for this work from any of the following organizations:National Institutes of Health, Wellcome Trust,Howard Hughes Medical Institute,and other(s).
Abstract V Submit five to eight key words appropriate for indexing purposes.Do not repeat words or terms used in the title.
Keywords V An informative abstract of approximately250words should state concisely the purpose and pertinent methods of the study,as well as the findings and specific conclusions.This abstract should be suitable,without rewording,for use by abstracting journals and indexing services.
Text V The text of the manuscript should begin on a new page and be arranged as follows:Introduction,Materials and Methods,Results,and Discussion.The use of subheadings and paragraph titles within these headings is encouraged for sake of clarity.For standard abbreviations, authors should follow the guidelines in the Council of Biology Editors Style Manual,Fifth Edition.All other abbreviations should be defined when first used and listed in a footnote.Authors are encouraged to use 0019(e-mail:Shock@;telephone:205-975-0118;fax205-975-Editorial Office(e-mail:Shock@).